Lab study explores cannabis compounds for inflammatory disease treatment

NCT ID NCT06842316

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how natural cannabis compounds (phytocannabinoids) affect immune cells from 100 people with chronic inflammatory diseases like rheumatoid arthritis, lupus, and Crohn's disease. Researchers will take a blood sample and expose the cells to different cannabis extracts in a lab to see if they reduce inflammation. The goal is to find which cannabis profiles work best, but this is early lab research, not a treatment for patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SJOGREN'S SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ankylosing spondylitis inflammatory bowel disease inflammatory disease psoriatic arthritis rheumatoid arthritis Sjogren syndrome spondyloarthropathy systemic lupus erythematosus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • CHU d'ORLEANS

    RECRUITING

    Orléans, 45067, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact